These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16563840)

  • 1. Intermittent parathyroid hormone therapy to increase bone formation.
    Thomas T
    Joint Bone Spine; 2006 May; 73(3):262-9. PubMed ID: 16563840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
    Ito M
    Clin Calcium; 2007 Dec; 17(12):1858-64. PubMed ID: 18057661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of male osteoporosis with parathyroid hormone.
    Bilezikian JP; Kurland ES
    Calcif Tissue Int; 2001 Oct; 69(4):248-51. PubMed ID: 11730261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
    Pierroz DD; Bonnet N; Baldock PA; Ominsky MS; Stolina M; Kostenuik PJ; Ferrari SL
    J Biol Chem; 2010 Sep; 285(36):28164-73. PubMed ID: 20558734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Johnson CS; Vafai HT; Kaplan KC; Bailey J; Capwell B; Fraser F; Hansen L; Ramsay H; Shadoan M; Lees CJ; Thomsen JS; Mosekilde L
    Bone; 1999 Sep; 25(3):301-9. PubMed ID: 10495134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone--a drug for orthopedic surgery?
    Skripitz R; Aspenberg P
    Acta Orthop Scand; 2004 Dec; 75(6):654-62. PubMed ID: 15762254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
    Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
    Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein malnutrition attenuates bone anabolic response to PTH in female rats.
    Ammann P; Zacchetti G; Gasser JA; Lavet C; Rizzoli R
    Endocrinology; 2015 Feb; 156(2):419-28. PubMed ID: 25396268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
    Motyl KJ; McCauley LK; McCabe LR
    J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy.
    de Bakker CM; Altman AR; Tseng WJ; Tribble MB; Li C; Chandra A; Qin L; Liu XS
    Bone; 2015 Apr; 73():198-207. PubMed ID: 25554598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic imaging of treatment in osteoporosis: PTH].
    Ito M
    Clin Calcium; 2011 Jul; 21(7):1067-73. PubMed ID: 21719988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphological analysis of bone dynamics and metabolic bone disease. Effects of parathyroid hormone on bone tissue].
    Miyakoshi N
    Clin Calcium; 2011 Apr; 21(4):575-81. PubMed ID: 21447925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone in the treatment of osteoporosis.
    Fujita T
    BioDrugs; 2001; 15(11):721-8. PubMed ID: 11707147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD; Wronski TJ
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.